Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma-Reference-Cited by-同舟云学术

Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma

Published:2016-06-06 Issue:28 Volume:7 Page:44084-44095
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Obulkasim Askar¹,Ylstra Bauke²,van Essen Hendrik F.²,Benner Christian²,Stenning Sally³,Langley Ruth³,Allum William⁴,Cunningham David⁵,Inam Imran⁶,Hewitt Lindsay C.⁶⁷,West Nicolas P.⁶,Meijer Gerrit A.²,van de Wiel Mark A.¹⁸,Grabsch Heike I.⁶⁷

Affiliation:

1. Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, NL

2. Department of Pathology, VU University Medical Center, Amsterdam, NL

3. MRC Clinical Trials Unit at University College London, London, UK

4. Department of Surgery, Royal Marsden NHS Foundation Trust, London, UK

5. Department of Gastrointestinal Oncology, Royal Marsden NHS Foundation Trust, London and Surrey, UK

6. Section of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK

7. Department of Pathology and GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, NL

8. Department of Mathematics, VU University, Amsterdam, NL

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Karyotype Evolution in Response to Chemoradiotherapy and Upon Recurrence of Esophageal Adenocarcinomas;2024-03-02

2. Entropy-Based Analysis of DNA Sequences and IGHV Mutational Status in Chronic Lymphocytic Leukemia: Predicting Patient Survival;IFMBE Proceedings;2024

3. Targets, Therapies and the Role of Serial Biopsies for Prognostication and Assessing Changes to Tumour Biology in Oesophageal and Oesophagogastric Junction Cancers;Oncology & Haematology;2022

4. Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-10-15

5. Microfluidic Single-Cell Proteomics Assay Chip: Lung Cancer Cell Line Case Study;Micromachines;2021-09-23